Fosun-controlled Gland Pharma seeking $3.3 bn valuation in IPO

Premium

Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, is seeking a valuation of as much as Rs 24,492 crore ($3.3 billion at current exchange rates) through the share sale. Hyderabad-based Gland Pharma, which is majority-owned by China’s Shanghai Fosun Pharmaceutical ......